EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program

John C Myers iD, Maxwell A Braverman iD, Angelo Ciaraglia iD, Rahaf Alkhateb, Lauran Barry, Zachary Brooke, Jeffrey Chang, Hanzhang Wang, Rafael Elenes, Byron Hepburn, Kayla Ireland, Rachelle Jonas und 9 weitere

Transfusion · 2023

DOI: 10.1111/trf.17331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2023. Verfasst von John C Myers und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, UT Health San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Postpartum Hemorrhage, Placenta Accreta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postpartum hemorrhage (PPH) is one of the leading causes of obstetric complications. The goal of this study was to identify risk factors for obstetric (OB) massive transfusion (MT) and determine the feasibility of developing a low‐titer group O RhD‐positive whole blood (LTO + WB) protocol for OB hemorrhage. Study Design and Methods A retrospective study of OB patients who received transfusion within 24 h. MT patients were those who received >3 U of pRBC within 1 h or > 10 U in 24 h. Patient demographics, OB history, comorbidities, blood type, antibody status, and known risk factors for PPH and maternal‐fetal outcomes were compared. Logistic regression was used for univariate and multivariate analyses.

Results

Of the 610 transfused OB patients, 12.0% ( n = 73) required MT. Groups were well matched for body mass index (BMI), maternal comorbidities, and history of spontaneous vaginal deliveries. The incidence of the previous cesarean section was higher in the MT group. Exactly 93.9% of patients were RhD‐positive and 3.77% of all patients possessed an antibody on pretransfusion testing. Patients with MT had a longer length of stay (LOS), higher rate of intensive care unit (ICU) admission, fetal death, and hysterectomy. Multivariate analysis found age >35, PPH, placenta percreta, accreta, and increta to be significant ( p < .05) risk factors for MT.

Discussion

Patients over 35 years and those with abnormal placentation are at increased risk of requiring MT. With a time to delivery of 2 days, potential MT patients can be identified early, and with a 94% rate of RhD‐positive+, they are eligible to receive low‐titer O whole blood (LTOWB) providing hemostatic resuscitation with reduced donor exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postpartum HemorrhagePlacenta AccretaHumansPregnancyFemaleCesarean SectionRetrospective StudiesDelivery, ObstetricRisk FactorsHysterectomy

Stichwörter der Autor:innen

transfusion practices (OB GYN)transfusion practices (Surgical)transfusion practices (adult)

Autor:innen und Institutionen

  • Department of Surgery, UT Health San Antonio, San Antonio, Texas, USA.
  • Department of Pathology, UT Health San Antonio, San Antonio, Texas, USA.
  • Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, Texas, USA.
  • Department of Urology, UT Health San Antonio, San Antonio, Texas, USA.
  • Department of Anesthesia, UT Health San Antonio, San Antonio, Texas, USA.
  • Military Health Institute, UT Health San Antonio, San Antonio, Texas, USA.

ORCID-Profile: John C Myers, Maxwell A Braverman, Angelo Ciaraglia

Zitieren

APA

Myers, J. C., Braverman, M. A., Ciaraglia, A., Alkhateb, R., Barry, L., Brooke, Z., Chang, J., Wang, H., Elenes, R., Hepburn, B., Ireland, K., Jonas, R., Nelson, J., Pedraza, S., Song, J., Nicholson, S., Eastridge, B., Stewart, R., Greebon, L., …, & Jenkins, D. (2023). Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program. Transfusion. https://doi.org/10.1111/trf.17331

Vancouver

Myers JC, Braverman MA, Ciaraglia A, Alkhateb R, Barry L, Brooke Z, et al. Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program. Transfusion. 2023. doi:10.1111/trf.17331

BibTeX
@article{Myers2023,
  author = {Myers, John C and Braverman, Maxwell A and Ciaraglia, Angelo and Alkhateb, Rahaf and Barry, Lauran and Brooke, Zachary and Chang, Jeffrey and Wang, Hanzhang and Elenes, Rafael and Hepburn, Byron and Ireland, Kayla and Jonas, Rachelle and Nelson, Jeremy and Pedraza, Santiago and Song, Jun and Nicholson, Susannah and Eastridge, Brian and Stewart, Ronald and Greebon, Leslie and Xenakis, Elly and Jenkins, Donald},
  title = {Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17331}
}
Kostenlos starten →